Hi Pivalde,
im sure Sinclair is pushing this line of research - Alterity is fully aware :
Funding: This work was carried out with the support of Alterity Therapeutics, Newark, CA to DJK (alteritytherapeutics.com). Alterity provided partial support for Ms. Bailey’s stipend and for supplies required to conduct this research. Further support for the Kosman Lab is provided by grant RO1 NS102337 to DJK from the National Institutes of Health of the United States (www.nih.gov). The funders played no role in the design nor conduct of this research. The contributions to this manuscript provided by Alterity scientific staff are acknowledged as appropriate.
NEW PAPER about ATH434 and endothelial cells !!!!, page-17
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $168.8K | 33.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 41248698 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 19271266 | 14 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 16.7 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.5¢ | 10016772 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| ATH (ASX) Chart |